Current Value of Holding

$573 Million

Shares

12.7 Million

% of Portfolio

0.43%

Average Buy Price

$39.5

Avg closing price
Price range

32 PRIMECAP Management GSK Plc Trades

PRIMECAP Management's position in GSK Plc is currently worth $573 Million. That's 0.43% of their equity portfolio (56th largest holding). The first GSK Plc trade was made in Q1 2013. Since then PRIMECAP Management bought shares seven more times and sold shares on 24 occasions. The stake costed the investor $504 Million, netting the investor a gain of 14% so far.

Avg closing price
Price range
Increased shares by 5.4% (+649 Thousand shares) Q1 2024
Avg closing price $41.24
Price range $37.51 - $43.58
Increased shares by 0.3% (+30.6 Thousand shares) Q4 2023
Avg closing price $35.90
Price range $34.17 - $37.56
Increased shares by 2.4% (+287 Thousand shares) Q3 2023
Avg closing price $35.49
Price range $33.81 - $38.07
Increased shares by 19.2% (+1.9 Million shares) Q2 2023
Avg closing price $35.87
Price range $33.60 - $38.32
Increased shares by 162.1% (+6.11 Million shares) Q1 2023
Avg closing price $34.99
Price range $33.50 - $36.43
Increased shares by 753.7% (+3.32 Million shares) Q4 2022
Avg closing price $33.31
Price range $30.00 - $37.92
Sold 20.0% shares (-110 Thousand shares) Q3 2022
Avg closing price $36.31
Price range $28.66 - $43.91
Sold 1.4% shares (-7.9 Thousand shares) Q2 2021
Avg closing price $38.44
Price range $35.82 - $40.66
Sold 0.6% shares (-3.2 Thousand shares) Q4 2019
Avg closing price $44.50
Price range $41.19 - $47.32
Sold 0.4% shares (-2.1 Thousand shares) Q3 2019
Avg closing price $41.15
Price range $39.68 - $42.68
Sold 2.1% shares (-12.3 Thousand shares) Q2 2019
Avg closing price $40.14
Price range $38.64 - $41.88
Sold 31.6% shares (-267 Thousand shares) Q4 2018
Avg closing price $39.40
Price range $37.07 - $41.87
Sold 19.5% shares (-204 Thousand shares) Q3 2018
Avg closing price $40.64
Price range $38.99 - $41.87
Sold 2.3% shares (-25.1 Thousand shares) Q1 2018
Avg closing price $37.26
Price range $35.49 - $39.38
Sold 0.3% shares (-3 Thousand shares) Q4 2017
Avg closing price $36.96
Price range $34.66 - $41.10
Sold 1.7% shares (-18.5 Thousand shares) Q2 2017
Avg closing price $42.65
Price range $40.68 - $44.37
Sold 1.4% shares (-15.1 Thousand shares) Q4 2016
Avg closing price $39.52
Price range $37.39 - $43.44
Sold 0.6% shares (-6.9 Thousand shares) Q3 2016
Avg closing price $43.86
Price range $42.50 - $45.49
Sold 0.1% shares (-900 shares) Q2 2016
Avg closing price $42.14
Price range $40.04 - $43.47
Sold 73.7% shares (-3.13 Million shares) Q1 2016
Avg closing price $39.84
Price range $38.54 - $42.05

News about GSK Plc - ADR and PRIMECAP Management

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!